These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23144072)

  • 1. Economic evaluation of different treatment modalities in acute kidney injury.
    De Smedt DM; Elseviers MM; Lins RL; Annemans L
    Nephrol Dial Transplant; 2012 Nov; 27(11):4095-101. PubMed ID: 23144072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients.
    Ethgen O; Schneider AG; Bagshaw SM; Bellomo R; Kellum JA
    Nephrol Dial Transplant; 2015 Jan; 30(1):54-61. PubMed ID: 25326472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial aspects of renal replacement therapy in acute kidney injury.
    James MT; Tonelli M;
    Semin Dial; 2011; 24(2):215-9. PubMed ID: 21517991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
    Lins RL; Elseviers MM; Van der Niepen P; Hoste E; Malbrain ML; Damas P; Devriendt J;
    Nephrol Dial Transplant; 2009 Feb; 24(2):512-8. PubMed ID: 18854418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital costs and clinical characteristics of continuous renal replacement therapy patients: a continuous ethical dilemma.
    Coustasse A
    J Hosp Mark Public Relations; 2008; 18(2):187-95. PubMed ID: 19042868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina.
    Garay OU; Palacios A; Pichon-Riviere A; Augustovski F; Martí SG; Hernández-Vásquez A; López ET; Rosa-Díez G; Bardach A
    Value Health Reg Issues; 2019 Dec; 20():142-148. PubMed ID: 31426017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of continuous renal replacement therapy in acute renal failure.
    Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M;
    Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy.
    Oh HJ; Park JT; Kim JK; Yoo DE; Kim SJ; Han SH; Kang SW; Choi KH; Yoo TH
    Nephrol Dial Transplant; 2012 Feb; 27(2):589-94. PubMed ID: 21712489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury.
    Singh A; Hussain S; Kher V; Palmer AJ; Jose M; Antony B
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):27-35. PubMed ID: 33934689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
    Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
    Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
    J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G; Fraeman K; Teerlink JR; Mullahy J; Salon J; Sterz R; Durtschi A; Padley RJ
    Eur J Health Econ; 2010 Apr; 11(2):185-93. PubMed ID: 19582491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT.
    Kimman ML; Dirksen CD; Voogd AC; Falger P; Gijsen BC; Thuring M; Lenssen A; van der Ent F; Verkeyn J; Haekens C; Hupperets P; Nuytinck JK; van Riet Y; Brenninkmeijer SJ; Scheijmans LJ; Kessels A; Lambin P; Boersma LJ
    Eur J Cancer; 2011 May; 47(8):1175-85. PubMed ID: 21257305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating acute kidney injury using continuous and intermittent renal replacement therapy.
    Caćić M
    Lijec Vjesn; 2013; 135(1-2):1-6. PubMed ID: 23607169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study.
    Srisawat N; Lawsin L; Uchino S; Bellomo R; Kellum JA;
    Crit Care; 2010; 14(2):R46. PubMed ID: 20346163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reimbursement and cost of acute kidney injury: a UK hospital perspective.
    Kolhe NV; Eldehni MT; Selby NM; McIntyre CW
    Nephron Clin Pract; 2014; 126(1):51-6. PubMed ID: 24514003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center.
    Vats HS; Dart RA; Okon TR; Liang H; Paganini EP
    Ren Fail; 2011; 33(7):698-706. PubMed ID: 21787161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.